I like the compromise ACT offers as much as anyone, it just might turn out to be a moot point in the long run. As for calling people, my point was that it would be unnecessary due to the news media reporting the RPE ESC trial. Fingers crossed the liberal media reports not only the company name but also makes a comparison between the two trials (GERN vs. ACT) plus contributes the additional information that it has such a compromise! This (my hope) would be enough. As for those whom cater to a more conservative crowd, It's JMO that even if you do your part and educate them they will continue to point out the advances made elsewhere and attempt, in return and on your dime, to get you to see things their way.
FWIW, best of luck doing your part.
